Enhabit (EHAB) EVP Jolley sells 5,586 common shares in open market

Rhea-AI Filing Summary

Enhabit, Inc. executive Julie Diane Jolley, EVP of Home Health Operations, reported open-market sales of company common stock. She sold a total of 5,586 shares in two transactions of 2,793 shares each on March 9 and 10, 2026, at a price of $13.63 per share. After these sales, she directly holds 137,130 Enhabit common shares.

Insider Trade Summary 10b5-1

Net Seller: 5,586 shares ($76,137)

Net Sell 2 txns

Insider Jolley Julie Diane

Role EVP of Home Health Operations

Sold 5,586 shs ($76K)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,793	$13.63	$38K
Sale	Common Stock	2,793	$13.63	$38K

Holdings After Transaction: Common Stock — 137,130 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jolley Julie Diane

(Last) (First) (Middle)

6688 N. CENTRAL EXPRESSWAY

SUITE 1300

(Street)

DALLAS TX 75206

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Enhabit, Inc. [ EHAB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP of Home Health Operations

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/09/2026		S		2,793	D	$13.63	139,923	D
Common Stock	03/10/2026		S		2,793	D	$13.63	137,130	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Sarah W. Braley, Attorney in Fact	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Enhabit (EHAB) report for Julie Diane Jolley?

Enhabit reported that EVP of Home Health Operations Julie Diane Jolley sold company common stock. She executed two open-market sales of Enhabit common shares, reflecting routine portfolio activity disclosed through a Form 4 insider trading report.

How many Enhabit (EHAB) shares did Julie Diane Jolley sell and at what price?

Julie Diane Jolley sold a total of 5,586 Enhabit common shares. The sales occurred in two equal blocks of 2,793 shares each, with both transactions reported at a price of $13.63 per share in the open market.

On what dates did the Enhabit (EHAB) insider share sales by Julie Diane Jolley occur?

The reported insider sales by Julie Diane Jolley occurred on March 9, 2026 and March 10, 2026. Each date involved an open-market sale of 2,793 Enhabit common shares, according to the Form 4 transaction details.

How many Enhabit (EHAB) shares does Julie Diane Jolley hold after these transactions?

After completing the reported open-market sales, Julie Diane Jolley holds 137,130 Enhabit common shares directly. This figure represents her remaining direct ownership position following the two Form 4 transactions disclosed for March 9 and March 10, 2026.

Were Julie Diane Jolley’s Enhabit (EHAB) trades option exercises or straight share sales?

The transactions were straight sales of Enhabit common stock, not option exercises. Both entries are classified as non-derivative, open-market sales of common shares, with no associated derivative securities listed in the filing’s derivative transaction summary.

Does the Enhabit (EHAB) Form 4 show any remaining derivative positions for Julie Diane Jolley?

The Form 4 derivative summary for Julie Diane Jolley is empty. That means the disclosed activity only involves non-derivative Enhabit common stock, with no unexercised options or other derivative securities reported in this particular insider filing.